Androstanazol

Androstanazol Uses, Dosage, Side Effects, Food Interaction and all others data.

Androstanazol is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Androstanazol is derived from testosterone, and has been abused by several high profile professional athletes.

Androstanazol is a synthetic anabolic-androgenic steroid (AAS), which promotes cell growth (anabolism) and development/maintenance of masculine characteristics (androgenism).

Trade Name Androstanazol
Availability Discontinued
Generic Stanozolol
Stanozolol Other Names Androstanazol, Androstanazole, Estanozolol, Stanozolol
Related Drugs Orladeyo, danazol, Firazyr, Haegarda, Ruconest, Berinert, Danocrine, Cinryze, Kalbitor
Type
Formula C21H32N2O
Weight Average: 328.4916
Monoisotopic: 328.251463656
Groups Approved, Vet approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Androstanazol
Androstanazol

Uses

Androstanazol is an anabolic steroid used to manage hereditary angioedema.

Androstanazol is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema. C1-inhibitor is a protease that inhibits the complement system (part of the innate immune system), a biochemical chain of reactions which assists the body in removing pathogens from the body. Androstanazol may help control attacks of hereditary angioedema. Androstanazol can be administered orally or intramuscularly.

Androstanazol is also used to associated treatment for these conditions: Hereditary Angioedema

How Androstanazol works

Androstanazol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP).

Androstanazol Cholesterol interaction

[Major] Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels.

These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease.

Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen.

Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.

Half Life

24 hours

Innovators Monograph

You find simplified version here Androstanazol

*** Taking medicines without doctor's advice can cause long-term problems.
Share